NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Keya Medical

Keya Medical

Private
BeijingHealthcare & Life Scienceshttps://www.keyamedical.com/

Last Round

Series D

Extension

Jul 22, 2021

Est. Valuation

$898.3M

Total Funding Raised

$325.81M

Company Overview

Keya Medical is a medical technology company that develops and provides artificial intelligence-based software and devices for disease diagnosis and treatment, specializing in deep learning solutions for cardiology, neurology, and pulmonology.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Medical Devices

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

medical imaging AISaMDsoftware as a medical devicedigital pathologyPACS integrationradiology AIdiagnostic imagingmedical image reconstructionclinical decision supportAI pathologyusage-based SaaShealthcare softwaremedtechdiagnostic workflowRIS integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Keya Medical Comparables

Compare Keya Medical with similar companies based on industry and business-model similarity.

Keya Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aidoc
87%
Viz.ai
83%
Gleamer
82%

Keya Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series D ExtensionJul 22, 2021
Series DJan 14, 2021
Series CNov 12, 2020
Series B ExtensionAug 13, 2020
StrategicFeb 1, 2020
Series C Extension
Dec 7, 2018

Keya Medical Investors

Notable investors and investment history

Keya Medical investors
InvestorRounds
Alwin CapitalStrategic, Series B Extension, Series C
IDG CapitalStrategic, Series C
INcapital VenturesSeries D
CCIC CapitalSeries D
Taihe CapitalSeries C Extension
Tasly Holding GroupSeries C
Yueyin Medical FundSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 20, 2025

    Will be exhibiting at the RSNA 2025 conference.

  • Jul 8, 2025

    Expanding US offices to increase regional coverage.

Keya Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Keya Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Keya Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range44
Year Founded2016
Last FundingJul 22, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.